Literature DB >> 29524426

The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypes.

Ornit Chiba-Falek1, William K Gottschalk2, Michael W Lutz2.   

Abstract

The TOMM40 poly-T is a polymorphism in intron 6 of the TOMM40 gene, which is adjacent to and in linkage disequilibrium with APOE. Roses et al. identified the association between the length of TOMM40 poly-T with the risk and age of onset of late-onset Alzheimer's disease (LOAD). Following the original discovery, additional studies found associations between the TOMM40 poly-T and LOAD-related phenotypes independent of APOE genotypes, while others did not replicate these associations. Furthermore, the identity of the TOMM40 poly-T risk allele has been controversial between different LOAD-related phenotypes. Here, we propose a framework to address the conflicting findings with respect to the TOMM40 poly-T allele associations with LOAD phenotypes and their functional effects. The framework is used to interpret previous studies as means to gain insights regarding the nature of the risk allele, very long versus short. We suggest that the identity of the TOMM40 poly-T risk allele depends on the phenotype being evaluated, the ages of the study subjects at the time of assessment, and the context of the APOE genotypes. In concluding remarks, we outline future studies that will inform the mechanistic interpretation of the genetic data.
Copyright © 2018 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APOE; Brain imaging; Cognitive performance; Late-onset Alzheimer's disease; TOMM40 poly-T

Mesh:

Substances:

Year:  2018        PMID: 29524426      PMCID: PMC5938113          DOI: 10.1016/j.jalz.2018.01.015

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  63 in total

1.  A TOMM40 poly-T variant modulates gene expression and is associated with vocabulary ability and decline in nonpathologic aging.

Authors:  A Payton; P Sindrewicz; V Pessoa; H Platt; M Horan; W Ollier; V J Bubb; N Pendleton; J P Quinn
Journal:  Neurobiol Aging       Date:  2015-12-08       Impact factor: 4.673

2.  Genome-wide association analysis of age-at-onset in Alzheimer's disease.

Authors:  M I Kamboh; M M Barmada; F Y Demirci; R L Minster; M M Carrasquillo; V S Pankratz; S G Younkin; A J Saykin; R A Sweet; E Feingold; S T DeKosky; O L Lopez
Journal:  Mol Psychiatry       Date:  2011-10-18       Impact factor: 15.992

3.  Additional evidence for antagonistic pleiotropic effects of APOE.

Authors:  Henrik Zetterberg; David M Alexander; Demetrios A Spandidos; Kaj Blennow
Journal:  Alzheimers Dement       Date:  2009-01       Impact factor: 21.566

4.  Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system.

Authors:  O Chiba-Falek; R L Nussbaum
Journal:  Hum Mol Genet       Date:  2001-12-15       Impact factor: 6.150

5.  Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants.

Authors:  Davide Bruno; Jay J Nierenberg; James C Ritchie; Michael W Lutz; Nunzio Pomara
Journal:  Psychoneuroendocrinology       Date:  2011-07-30       Impact factor: 4.905

6.  Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline.

Authors:  Lei Yu; Michael W Lutz; Jose M Farfel; Robert S Wilson; Daniel K Burns; Ann M Saunders; Philip L De Jager; Lisa L Barnes; Julie A Schneider; David A Bennett
Journal:  Alzheimers Dement       Date:  2017-06-15       Impact factor: 21.566

Review 7.  Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription.

Authors:  Simon M Laws; Eugene Hone; Sam Gandy; Ralph N Martins
Journal:  J Neurochem       Date:  2003-03       Impact factor: 5.372

8.  Longitudinal modeling of cognitive aging and the TOMM40 effect.

Authors:  Richard J Caselli; Amylou C Dueck; Matthew J Huentelman; Michael W Lutz; Ann M Saunders; Eric M Reiman; Allen D Roses
Journal:  Alzheimers Dement       Date:  2012-11       Impact factor: 21.566

9.  Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model.

Authors:  S E Gabriel; K N Brigman; B H Koller; R C Boucher; M J Stutts
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

10.  TOMM40 association with Alzheimer disease: tales of APOE and linkage disequilibrium.

Authors:  Rita J Guerreiro; John Hardy
Journal:  Arch Neurol       Date:  2012-10
View more
  20 in total

1.  TOMM40 '523 Associations with Baseline and Longitudinal Cognition in APOE ɛ3 Homozygotes.

Authors:  Amber Watts; Heather M Wilkins; Elias Michaelis; Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

2.  Analysis of pleiotropic genetic effects on cognitive impairment, systemic inflammation, and plasma lipids in the Health and Retirement Study.

Authors:  Michael W Lutz; Ramon Casanova; Santiago Saldana; Maragatha Kuchibhatla; Brenda L Plassman; Kathleen M Hayden
Journal:  Neurobiol Aging       Date:  2019-03-06       Impact factor: 4.673

3.  Protective Variants in Alzheimer's Disease.

Authors:  Shea J Andrews; Brian Fulton-Howard; Alison Goate
Journal:  Curr Genet Med Rep       Date:  2019-01-24

Review 4.  Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders.

Authors:  Anna Morozova; Yana Zorkina; Olga Abramova; Olga Pavlova; Konstantin Pavlov; Kristina Soloveva; Maria Volkova; Polina Alekseeva; Alisa Andryshchenko; Georgiy Kostyuk; Olga Gurina; Vladimir Chekhonin
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

Review 5.  The Current Landscape of Prevention Trials in Dementia.

Authors:  Jonathan Lee; Rebecca Sitra Howard; Lon S Schneider
Journal:  Neurotherapeutics       Date:  2022-05-19       Impact factor: 6.088

6.  A U-statistics for integrative analysis of multilayer omics data.

Authors:  Xiaqiong Wang; Yalu Wen
Journal:  Bioinformatics       Date:  2020-04-15       Impact factor: 6.937

7.  TOMM40-APOE haplotypes are associated with cognitive decline in non-demented Blacks.

Authors:  Kacie D Deters; Elizabeth C Mormino; Lei Yu; Michael W Lutz; David A Bennett; Lisa L Barnes
Journal:  Alzheimers Dement       Date:  2021-02-13       Impact factor: 21.566

8.  System-Level Analysis of Alzheimer's Disease Prioritizes Candidate Genes for Neurodegeneration.

Authors:  Jeffrey L Brabec; Montana Kay Lara; Anna L Tyler; J Matthew Mahoney
Journal:  Front Genet       Date:  2021-04-06       Impact factor: 4.599

9.  Protective association of the ε2/ε3 heterozygote with Alzheimer's disease is strengthened by TOMM40-APOE variants in men.

Authors:  Alexander M Kulminski; Ian Philipp; Yury Loika; Liang He; Irina Culminskaya
Journal:  Alzheimers Dement       Date:  2021-07-26       Impact factor: 21.566

10.  Mitonuclear interactions influence Alzheimer's disease risk.

Authors:  Shea J Andrews; Brian Fulton-Howard; Christopher Patterson; G Peggy McFall; Alden Gross; Elias K Michaelis; Alison Goate; Russell H Swerdlow; Judy Pa
Journal:  Neurobiol Aging       Date:  2019-09-24       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.